EFMC-ISMC Virtual Event 2020

Confirmed Speakers


Confirmed Speakers

QBW251: a Potent Potentiator of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel for Treatment of Respiratory Diseases
Dr Atwood CHEUNGDr Atwood CHEUNG
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Cambridge, United States)

Read more
The Discovery of BMS-986177/JNJ-70033093; a FXIa Inhibitor for the Prevention and Treatment of Thrombosis
Dr Andrew DILGERDr Andrew DILGER
(BRISTOL-MYERS SQUIBB, Princeton, United States)

Read more
First Time Disclosure of BI 425809, a GlyT1 Inhibitor for the Treatment of CNS Diseases
Dr Riccardo GIOVANNINIDr Riccardo GIOVANNINI
(BOEHRINGER INGELHEIM, Biberach, Germany)

Read more
Cannabinoid Receptor 2 Agonists on Their Way to Clinics – How Industrial Drug Discovery and Academic Research Can Cross-Fertilize Each Other
Dr Uwe GRETHERDr Uwe GRETHER
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)

Read more
The Discovery of LTT462, a Potent ERK Inhibitor for the Treatment of Advanced Solid Tumors Harboring MAPK Pathway Alterations
Dr Wooseok HANDr Wooseok HAN
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Songpa-gu, Korea, South)

Read more
Discovery of SCO-267, a First-in-class GPR40 Full Agonist, as a Promising Candidate for the Treatment of Type 2 Diabetes Mellitus, Obesity, and NASH
Dr Naoyoshi NOGUCHIDr Naoyoshi NOGUCHI
(SCOHIA PHARMA, INC., Fujisawa, Japan)

Read more
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor, as an Inhaled Treatment for Asthma
Dr Matthew W. D. PERRYDr Matthew W. D. PERRY
(ASTRAZENECA, Gothenburg, Sweden)

Read more
Discovery of the AhR Antagonist BAY 2416964; a New Clinical Candidate for Cancer Immunotherapy
Dr Norbert SCHMEESDr Norbert SCHMEES
(BAYER PHARMACEUTICALS, Berlin, Germany)

Read more
GB1211, the First Orally Available Galectin/Galectin 3 Inhibitor to Be Taken into Clinic as a Potential Treatment for Non Alcoholic Steatohepatitis (NASH)
Dr Fredrik ZETTERBERGDr Fredrik ZETTERBERG
(GALECTO BIOTECH, Gothenburg, Sweden)

Read more

We thank the EFMC-ISMC 2021 Sponsors for their support!

Copyright 2022 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys